Published in Diagn Pathol on May 22, 2014
Sirtuins in glucose and lipid metabolism. Oncotarget (2017) 0.78
Acute Treatment of Resveratrol Alleviates Doxorubicin-Induced Myotoxicity in Aged Skeletal Muscle Through SIRT1-Dependent Mechanisms. J Gerontol A Biol Sci Med Sci (2015) 0.77
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature (2002) 10.52
Extended longevity in mice lacking the insulin receptor in adipose tissue. Science (2003) 8.53
Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science (2007) 4.80
Evolutionary medicine: from dwarf model systems to healthy centenarians? Science (2003) 4.31
Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A (1987) 4.21
A conserved regulatory system for aging. Cell (2001) 4.19
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol (2008) 3.74
Growth factors and cancer. Cancer Res (1986) 3.48
Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev (2006) 2.47
The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem (2008) 2.20
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res (2002) 1.96
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet (1995) 1.77
Elevated insulin receptor content in human breast cancer. J Clin Invest (1990) 1.70
A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res (1998) 1.60
Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res (1990) 1.57
Control of cell survival by IGF signaling pathways. Growth Horm IGF Res (2002) 1.56
Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. Oncogene (2001) 1.51
Evidence from monoclonal antibody studies that insulin stimulates deoxyribonucleic acid synthesis through the type I somatomedin receptor. J Clin Endocrinol Metab (1985) 1.49
Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Cancer Res (2003) 1.44
The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des (2007) 1.43
The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy. Clin Cancer Res (2005) 1.38
Insulin-like growth factor expression in human cancer cell lines. J Biol Chem (1996) 1.28
Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest (1988) 1.26
A fibrosarcoma with hypoglycaemia and a high serum-insulin level. Lancet (1962) 1.21
Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res (1997) 1.19
Sir2 mediates apoptosis through JNK-dependent pathways in Drosophila. Proc Natl Acad Sci U S A (2008) 1.19
p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. Proc Natl Acad Sci U S A (1998) 1.08
Autocrine and paracrine growth regulation of human breast cancer. J Steroid Biochem (1986) 1.06
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer. Diagn Pathol (2013) 1.01
Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer. Clin Cancer Res (2008) 1.01
Perturbation by insulin of human breast cancer cell cycle kinetics. Cancer Res (1984) 0.98
PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2. Biochem Biophys Res Commun (2005) 0.97
The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling. Mol Cancer Ther (2004) 0.96
Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res Treat (1998) 0.96
The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors. J Cancer Res Clin Oncol (1999) 0.95
Hormone binding by human mammary carcinoma. Cancer Res (1977) 0.94
Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. Cancer Res (1984) 0.93
Stress-induced premature senescence in hTERT-expressing ataxia telangiectasia fibroblasts. J Biol Chem (2003) 0.93
Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors. Breast Cancer Res Treat (1998) 0.91
The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer. Diagn Pathol (2013) 0.90
A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model. Oncogene (2005) 0.90
Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. Br J Cancer (1998) 0.90
Insulin receptor regulation in cultured human tumor cells. Cancer Res (1983) 0.90
Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. Horm Res (1986) 0.89
Expression of p53, p21/WAF/CIP, Bcl-2, Bax, Bcl-x, and Bak in radiation-induced apoptosis in testicular germ cell tumor lines. Int J Radiat Oncol Biol Phys (1998) 0.88
Insulin-induced enhancement of antitumoral response to methotrexate in breast cancer patients. Cancer Chemother Pharmacol (2003) 0.84
Insulin, chemotherapy, and the mechanisms of malignancy: the design and the demise of cancer. Med Hypotheses (2000) 0.82
Correlation of substance(s) immunologically cross-reactive with insulin, glucose and growth hormone in Hodgkin lymphoma patients. Cancer Lett (1982) 0.82
Insulin and glucagon secretion by renal adenocarcinoma. Cancer (1981) 0.81
Sporadic amplification of the insulin receptor gene in human breast cancer. J Endocrinol Invest (1997) 0.80
Characteristics of membrane transport of methotrexate by cultured human breast cancer cells. Biochem Pharmacol (1981) 0.79
Metabolic modification by insulin enhances methotrexate cytotoxicity in MCF-7 human breast cancer cells. Eur J Cancer Clin Oncol (1981) 0.78
Insulin binding by normal and neoplastic colon tissue. Int J Cancer (1985) 0.78
Structure of insulin/insulin-like growth factor-1 receptors on the insulinoma cell, RIN-m5F. Biochem Biophys Res Commun (1984) 0.77
Synthesis and antitumor activity of 5-trifluoromethyl-2,4- dihydropyrazol-3-one nucleosides. Molecules (2004) 1.03
Composition of the essential oil of wild growing Artemisia vulgaris from Erie, Pennsylvania. Nat Prod Commun (2012) 0.78